GeneCentric CEO: It is ‘starting to become more challenging to fund a biotech company’
WRAL TechWire discusses the future of life science, the difference between RNA and DNA, and the current and future funding environment for biotech companies with Dr. Michael Milburn, CEO of GeneCentric.
Read More
